Glucocorticoid-induced normotensive scleroderma renal crisis: A report on two cases and a review of the literature in Japan

3Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

We herein report the findings of 2 cases of normotensive scleroderma renal crisis (SRC) that developed soon after the commencement of a glucocorticoid therapy. We also review 8 cases of normotensive SRC reported in Japan, including our cases. The common characteristics of these 8 cases are as follows: the recent onset of systemic sclerosis, the presence of diffuse skin sclerosis, the presence of myositis and/or serositis, a high titer of antinuclear antibody and positivity for anti-Scl-70 antibody. In 7 of the 8 patients, thrombotic microangiopathy developed within one month of starting the glucocorticoid treatment. We should be careful with the use of glucocorticoids in systemic sclerosis patients exhibiting these features in order to avoid cases of normotensive SRC. © 2013 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Maruyama, A., Nagashima, T., Ikenoya, K., Aoki, Y., Matsuyama, Y., Iwamoto, M., & Minota, S. (2013). Glucocorticoid-induced normotensive scleroderma renal crisis: A report on two cases and a review of the literature in Japan. Internal Medicine, 52(16), 1833–1837. https://doi.org/10.2169/internalmedicine.52.0400

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free